Adenoviral Keratoconjunctivitis
Conditions
Brief summary
Povidone-iodine 2% eye drop versus artificial tear drop for treatment of adenoviral keratoconjunctivitis
Detailed description
Diagnosed EKC patients will be devided into two groups,first group will undergo povidone-iodine 2% eye drop four times a day and the control group will be treated only by artificial tear drops,they will be examined 3 months later and evaluations and data collections for the final comparison will be done.
Interventions
Povidone-iodine 2% eye drop versus artificial tear drop for treatment of adenoviral keratoconjunctivitis
Sponsors
Farabi Eye Hospital
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE
Eligibility
Sex/Gender
ALL
Age
17 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* Patients suspected for viral conjunctivitis
Exclusion criteria
* Allergic to iodized materials * Age under 17
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Povidone-iodine 2% eye drop versus artificial tear drop for treatment of adenoviral keratoconjunctivitis | 3 months | Decreased patient's symptoms |
| Povidone-iodine 2% eye drop | 3 months | Decreased viral load based on PCR results |
Contacts
Primary ContactMohammad Soleimani, professor
Backup ContactArash Mirzaei, Resident
Outcome results
None listed